因文蒂瓦 IVA
$3.80 +$0.17 (+4.68%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $3.83 +0.79%
开盘$3.63
昨收$3.63
当日区间$3.60 – $3.83
成交量2.22M
市值$897.69M
市盈率（TTM）–
股息率–
IVA 相关新闻
匹配 Inventiva 或代码 IVA 的头条新闻，按最新排序。
- UBS Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $12
- A Quick Look at Today's Ratings for Inventiva(IVA.US), With a Forecast Between $12 to $21
- A Quick Look at Today's Ratings for Inventiva(IVA.US), With a Forecast Between $10 to $21
- Stifel Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $15
- Piper Sandler Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $26
- Guggenheim Maintains Inventiva(IVA.US) With Buy Rating, Raises Target Price to $14 正面
- Analysts Conflicted on These Healthcare Names: BrightSpring Health Services, Inc. (BTSG), Inventiva (IVA) and Moderna (MRNA)
- Truist Financial Maintains Inventiva(IVA.US) With Buy Rating, Announces Target Price $13
- Cantor Fitzgerald Initiates Inventiva(IVA.US) With Buy Rating
- Barclays Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $18
- Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Rhythm Pharmaceuticals (RYTM) and Belite Bio, Inc. ADR (BLTE)
- TD Cowen Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $10
- Guggenheim Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $11
- A Quick Look at Today's Ratings for Inventiva(IVA.US), With a Forecast Between $12 to $20
- A Quick Look at Today's Ratings for Inventiva(IVA.US), With a Forecast Between $11 to $15
暂无评论——快来第一个聊聊 IVA。
登录后参与讨论。